Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
3.370
+0.080 (2.43%)
At close: Aug 28, 2025, 4:00 PM
3.380
+0.010 (0.30%)
After-hours: Aug 28, 2025, 7:47 PM EDT
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $49.37 million as of August 28, 2025. Its market cap has decreased by -59.50% in one year.
Market Cap
49.37M
Enterprise Value
38.02M
1-Year Change
-59.50%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since February 11, 1999, Veru Inc.'s market cap has increased from $17.00M to $49.37M, an increase of 190.42%. That is a compound annual growth rate of 4.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 48.20M | -49.37% |
Dec 31, 2024 | 95.20M | 41.25% |
Dec 29, 2023 | 67.40M | -84.17% |
Dec 30, 2022 | 425.70M | -9.69% |
Dec 31, 2021 | 471.40M | -22.24% |
Dec 31, 2020 | 606.20M | 178.20% |
Dec 31, 2019 | 217.90M | 148.46% |
Dec 31, 2018 | 87.70M | 44.48% |
Dec 29, 2017 | 60.70M | 112.98% |
Dec 30, 2016 | 28.50M | -32.30% |
Dec 31, 2015 | 42.10M | -62.74% |
Dec 31, 2014 | 113.00M | -53.73% |
Dec 31, 2013 | 244.20M | 18.60% |
Dec 31, 2012 | 205.90M | 63.80% |
Dec 30, 2011 | 125.70M | -19.63% |
Dec 31, 2010 | 156.40M | 24.42% |
Dec 31, 2009 | 125.70M | 30.39% |
Dec 31, 2008 | 96.40M | 38.31% |
Dec 31, 2007 | 69.70M | 85.87% |
Dec 29, 2006 | 37.50M | -7.64% |
Dec 30, 2005 | 40.60M | -11.74% |
Dec 31, 2004 | 46.00M | -14.34% |
Dec 31, 2003 | 53.70M | 88.42% |
Dec 31, 2002 | 28.50M | 139.50% |
Dec 31, 2001 | 11.90M | 80.30% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 655.34B |
Johnson & Johnson | 423.19B |
AbbVie | 365.79B |
UnitedHealth Group | 274.87B |
Novo Nordisk | 249.15B |
AstraZeneca | 247.25B |
Novartis AG | 245.07B |
Abbott Laboratories | 227.36B |